The Centers for Medicare & Medicaid lift a non-coverage decision for positron emission tomography in oncologic uses, but that’s not enough for the Medicare Imaging & Technology Alliance.
The Center for Medicare & Medicaid Services announced a shift in their decision regarding reimbursement for positron emission tomography scanning that will open the door for states to make their own coverage decisions for PET.
Lobbying group Medical Imaging & Technology Alliance supported the move, but chided the agency for failing to make the decision universal. CMS applied the shift specifically to oncologic tracers, despite MITA’s request.